Abstract
Blebbistatin is a small molecule inhibitor discovered in a screen for inhibitors of nonmuscle myosin IIA. We have examined the specificity and potency of the drug by assaying its effects on the actin-activated MgATPase assay of diverse members of the myosin superfamily. Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin IIA and IIB with IC50 values ranging from 0.5 to 5 μM. Interestingly, smooth muscle which is highly homologous to vertebrate nonmuscle myosin is only poorly inhibited (IC50=80 μM). The drug potently inhibits Dictyostelium myosin II, but poorly inhibits Acanthamoeba myosin II. Blebbistatin did not inhibit representative myosin superfamily members from classes I, V, and X.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Adelstein RS and Klee CB (1981) Purification and characterization of smooth muscle myosin light chain kinase. J Biol Chem 256: 7501–7509.
Avraham KB (2003) Molecular motors in sensory defects. In: Schliwa M. (ed.) Molecular Motors. (pp. 511–537) Wiley-VCH, Wenheim.
Berg JS, Powell BC and Cheney RE (2001) A millennial myosin census. Mol Biol Cell 12: 780–794.
Brzeska H and Korn ED (1996) Regulation of class I and class II myosins by heavy chain phosphorylation. J Biol Chem 271: 16983–16986.
Cheung A, Dantzig JA, Hollingworth S, Baylor SM, Goldman YE, Mitchison TJ and Straight AF (2002) A small-molecule inhibitor of skeletal muscle myosin II. Nature Cell Biology 4: 83–88.
Cuda G, Pate E, Cooke R and Sellers JR (1997) In vitro actin filament sliding velocities produced by mixtures of different types of myosin. Biophys J 72: 1767–1779.
Higuchi H and Takemori S (1989) Butanedione monoxime suppresses contraction and atpase activity of rabbit skeletal-muscle. J Biochem (Tokyo) 105: 638–643.
Hu A, Wang F and Sellers JR (2001) Mutations in human nonmuscle myosin IIA found in patients with May-Hegglin anomaly and Fechtner syndrome result in impaired enzymatic function. J Biol Chem 277: 46512–46517.
Kieke MC and Titus MA (2003) The myosin superfamily: an overview. In: Schliwa M (ed.) Molecular Motors. (pp. 3–44) Wiley-VCH, Weinheim.
Klee CB (1977) Conformational transition accompanying the binding of Ca2+ to the protein activator of 3¢,5¢-cyclic adenosine monophosphate phosphodiesterase. Biochemistry 16: 1017–1024.
Konhilas JP and Leinwand LA (2003) Myosin myopathies. In: Schliwa M (ed.) Molecular Motors. (pp. 473–495) Wiley-VCH, Weinheim.
Kovacs M, Wang F, Hu A, Zhang Y and Sellers JR (2003) Functional divergence of human cytoplasmic myosin II: kinetic characterization of the non-muscle IIA isoform. J Biol Chem, (in press).
Morano I, Chai GX, Baltas LG, Lamounier-Zepter V, Lutsch G, Kott M, Haase H and Bader M (2000) Smooth-muscle contraction without smooth-muscle myosin. Nat Cell Biol 2: 371–375.
Ostap EM (2002) 2,3-Butanedione monoxime (BDM) as a myosin inhibitor. J Musc Res Cell Motility 23: 305–308.
Pato MD, Sellers JR, Preston YA, Harvey EV and Adelstein RS (1996) Baculovirus expression of chicken nonmuscle heavy meromyosin II-B – Characterization of alternatively spliced isoforms. J Biol Chem 271: 2689–2695.
Sakamoto T, Wang F, Schmitz S, Xu YH, Xu Q, Molloy JE, Veigel C and Sellers JR (2003) Neck length and processivity of myosin V. J Biol Chem 278: 29201–29207.
Sellers JR (1985) Mechanism of the phosphorylation-dependent regulation of smooth muscle heavy meromyosin. J Biol Chem 260: 15815–15819.
Sellers JR (1999) Myosins. Oxford University Press, Oxford.
Sellers JR, Cuda G, Wang F and Homsher E (1993) Myosin-specific adaptations of motility assays. In: Scholey JM (ed.) Motility Assays for Motor Proteins (pp. 23–49), Academic Press, Inc., San Diego, CA, USA.
Sellin LC and Mcardle JJ (1994) Multiple effects of 2,3-butanedione monoxime. Pharmacology & Toxicology 74: 305–313.
Spudich JA and Watt S (1971) The regulation of rabbit skeletal muscle contraction. J Biol Chem 246: 4866–4871.
Straight AF, Cheung A, Limouze J, Chen I, Westwood NJ, Sellers JR and Mitchison TJ (2003) Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor. Science 299: 1743–1747.
Wang F, Chen L, Arcucci O, Harvey EV, Bowers B, Xu Y, Hammer JA III and Sellers JR (2000) Effect of ADP and ionic strength on the kinetic and motile properties of recombinant mouse myosin V. J Biol Chem 275: 4329–4335.
Wang F, Kovacs M, Hu AH, Limouze J, Harvey EV and Sellers JR (2003) Kinetic mechanism of non-muscle myosin IIB – Functional adaptations for tension generation and maintenance. J Biol Chem 278: 27439-27448
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Limouze, J., Straight, A.F., Mitchison, T. et al. Specificity of blebbistatin, an inhibitor of myosin II. J Muscle Res Cell Motil 25, 337–341 (2004). https://doi.org/10.1007/s10974-004-6060-7
Issue Date:
DOI: https://doi.org/10.1007/s10974-004-6060-7